NO20040221L - Peptides for cell removal or destruction - Google Patents

Peptides for cell removal or destruction

Info

Publication number
NO20040221L
NO20040221L NO20040221A NO20040221A NO20040221L NO 20040221 L NO20040221 L NO 20040221L NO 20040221 A NO20040221 A NO 20040221A NO 20040221 A NO20040221 A NO 20040221A NO 20040221 L NO20040221 L NO 20040221L
Authority
NO
Norway
Prior art keywords
peptides
destruction
cell removal
benign
harmful
Prior art date
Application number
NO20040221A
Other languages
Norwegian (no)
Other versions
NO335101B1 (en
Inventor
Paul A Averback
Original Assignee
Nymox Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/CA2002/001105 external-priority patent/WO2003008443A2/en
Application filed by Nymox Corp filed Critical Nymox Corp
Publication of NO20040221L publication Critical patent/NO20040221L/en
Publication of NO335101B1 publication Critical patent/NO335101B1/en

Links

Landscapes

  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Det beskrives fremgangsmåter for å behandle tilstander som krever fjerning eller destruksjon av skadelige eller uønskete celler i en pasient, så som benigne og maligne tumorer, ved anvendelse av forbindelser som inneholder eller er basert på peptider som omfatter en del av aminosyresekvensen av et neuralt trådprotein.Methods are described for treating conditions that require removal or destruction of harmful or unwanted cells in a patient, such as benign and malignant tumors, using compounds that contain or are based on peptides that comprise a portion of the amino acid sequence of a neural wire protein.

NO20040221A 2001-07-19 2004-01-16 NTP peptides for removing or destroying cells, materials comprising the NTP peptides, and using the NTP peptides for the manufacture of a medicament for the treatment of a condition which requires removal or destruction of cells. NO335101B1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US30616101P 2001-07-19 2001-07-19
US30615001P 2001-07-19 2001-07-19
US33144701P 2001-11-16 2001-11-16
PCT/CA2002/001105 WO2003008443A2 (en) 2001-07-19 2002-07-19 Peptides effective in the treatment of tumors and other conditions requiring the removal or destruction of cells

Publications (2)

Publication Number Publication Date
NO20040221L true NO20040221L (en) 2004-03-19
NO335101B1 NO335101B1 (en) 2014-09-15

Family

ID=35295613

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040221A NO335101B1 (en) 2001-07-19 2004-01-16 NTP peptides for removing or destroying cells, materials comprising the NTP peptides, and using the NTP peptides for the manufacture of a medicament for the treatment of a condition which requires removal or destruction of cells.

Country Status (1)

Country Link
NO (1) NO335101B1 (en)

Also Published As

Publication number Publication date
NO335101B1 (en) 2014-09-15

Similar Documents

Publication Publication Date Title
DK1442058T3 (en) Peptides effective for treating tumors and other conditions requiring cell removal or destruction
NO20040222L (en) Peptides for cell removal or destruction
EP0254032A3 (en) Neutral metalloendopeptidase inhibitors in the treatment of hypertension
NO974767L (en) Use of glial neurotrophic factor (GDNF) for the treatment of hearing disorders
NO20035231D0 (en) Peptides that can be used to treat tumors and other conditions that require the removal or destruction of cells
WO2002089747A3 (en) Compositions and methods for the therapy and diagnosis of prostate cancer
BR9707819A (en) Peptide immunogens
WO2003079020A3 (en) Methods and compositions for the identification, assessment, and therapy of small cell lung cancer
BR0207638A (en) Methods of using neural filament protein to treat tumors and other conditions that require cell removal or destruction
WO2000026245A3 (en) Human membrane transport proteins
WO1999049038A3 (en) Human calcium-binding proteins
DE60044350D1 (en) PROSTATE SPECIFIC GEN PCGEM1 AND METHODS OF USE FOR THE RECOGNITION, TREATMENT AND PREVENTION OF PROSTATE CANCER
NO20040221L (en) Peptides for cell removal or destruction
WO1994016085A3 (en) Hybrid proteins having cross-linking and tissue-binding activities
WO1999031128A3 (en) Human tumor necrosis factor-r2-like proteins
DE60334008D1 (en) REDUCED SLAM DEPENDENT CELL ENTRY
WO2003075844A3 (en) Compositions and methods for preventing and treating cancer via modulating ube1l, isg15 and/or ubp43

Legal Events

Date Code Title Description
CREP Change of representative

Representative=s name: PLOUGMANN & VINGTOFT, POSTBOKS 1003 SENTRUM, 0104

MM1K Lapsed by not paying the annual fees